Literature DB >> 19685935

Comparison of polyethylene glycol with and without electrolytes in the treatment of constipation in elderly institutionalized patients: a randomized, double-blind, parallel-group study.

Lauri Seinelä1, Ulla Sairanen, Tarmo Laine, Sangita Kurl, Tiina Pettersson, Pertti Happonen.   

Abstract

BACKGROUND: Polyethylene glycol (PEG) is a commonly used osmotic laxative. PEG with electrolytes is mixed with water, but PEG without electrolytes can also be mixed with, for example, juice, coffee or tea, making it more palatable. Laxatives, including PEG, are commonly used by the elderly, particularly those living in institutions. Few clinical studies, however, have investigated the use of PEG in this population.
OBJECTIVE: To test whether PEG 4000 without electrolytes (hypotonic PEG) is at least as effective and safe as PEG 4000 with electrolytes (isotonic PEG) in elderly institutionalized constipated patients. The acceptability of the treatments was also compared.
METHODS: This randomized, double-blind, parallel-group study was conducted at ten private assisted-living facilities or communal nursing homes in Finland. Eligible patients were required to have used isotonic PEG at a stable dose without any other treatment for constipation (except for Plantago ovata seeds) for at least 2 weeks prior to a run-in period. After the 1-week run-in, 62 patients (mean age 86 years; range 66-99 years) were randomly either switched to receive hypotonic PEG or continued to receive isotonic PEG, both dissolved in water, 12 g once or twice daily or once every other day, for 4 weeks. Stool frequency, stool consistency, stool straining and gastrointestinal symptoms were recorded. Safety laboratory tests were conducted before and after the treatment period. Acceptability was assessed at the end of the study.
RESULTS: At week 4, mean (SD) weekly stool frequencies in the hypotonic and isotonic PEG groups were 8.5 (4.5) and 8.4 (3.6), respectively. The mean stool frequency ratio (95% CI) was 0.90 (0.74, 1.10); thus, the PEG products were considered equally effective. At week 4, the proportion of patients with soft or normal stool consistency was higher in the hypotonic PEG group than in the isotonic PEG group (70% vs 52%), but this difference was not statistically significant. There were no differences between the groups in stool straining or gastrointestinal symptoms. In the safety laboratory tests, no clinically significant differences between the groups were detected, although plasma sodium level was statistically significantly lower in the hypotonic PEG group at the end of the study (137.7 vs 138.9 mmol/L, respectively; p = 0.012). Most patients were willing to continue their study treatment (85% in the hypotonic PEG and 63% in the isotonic PEG group; p = 0.070). Compared with only 12% of the patients receiving hypotonic PEG, however, 31% of the patients in the isotonic PEG group rated the taste of the study treatment as bad or very bad (p = 0.101).
CONCLUSION: Hypotonic PEG solution is as effective as isotonic PEG in the treatment of constipation in elderly institutionalized patients. Both treatments appear safe, well tolerated and, when dissolved in water, well accepted by the majority of the patients. When desired, switching from isotonic to hypotonic PEG can safely take place in elderly individuals without compromising efficacy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19685935     DOI: 10.2165/11316470-000000000-00000

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  23 in total

1.  Comparison of a low dose polyethylene glycol electrolyte solution with lactulose for treatment of chronic constipation.

Authors:  A Attar; M Lémann; A Ferguson; M Halphen; M C Boutron; B Flourié; E Alix; M Salmeron; F Guillemot; S Chaussade; A M Ménard; J Moreau; G Naudin; M Barthet
Journal:  Gut       Date:  1999-02       Impact factor: 23.059

2.  A randomized, placebo-controlled, multicenter study of the safety and efficacy of a new polyethylene glycol laxative.

Authors:  J A DiPalma; P H DeRidder; R C Orlando; B E Kolts; M B Cleveland
Journal:  Am J Gastroenterol       Date:  2000-02       Impact factor: 10.864

3.  Properties of azithromycin that enhance the potential for compliance in children with upper respiratory tract infections.

Authors:  J L Powers
Journal:  Pediatr Infect Dis J       Date:  1996-09       Impact factor: 2.129

4.  A randomized, multicenter, placebo-controlled trial of polyethylene glycol laxative for chronic treatment of chronic constipation.

Authors:  Jack A Dipalma; Mark Vb Cleveland; John McGowan; Jorge L Herrera
Journal:  Am J Gastroenterol       Date:  2007-03-31       Impact factor: 10.864

5.  Efficacy and optimal dose of daily polyethylene glycol 3350 for treatment of constipation and encopresis in children.

Authors:  D S Pashankar; W P Bishop
Journal:  J Pediatr       Date:  2001-09       Impact factor: 4.406

6.  An open-label study of chronic polyethylene glycol laxative use in chronic constipation.

Authors:  J A Di Palma; M Vb Cleveland; J McGowan; J L Herrera
Journal:  Aliment Pharmacol Ther       Date:  2007-03-15       Impact factor: 8.171

7.  A comparison of polyethylene glycol laxative and placebo for relief of constipation from constipating medications.

Authors:  Jack A DiPalma; Mark B Cleveland; John McGowan; Jorge L Herrera
Journal:  South Med J       Date:  2007-11       Impact factor: 0.954

8.  Anticholinergic drug use and bowel function in nursing home patients.

Authors:  M Monane; J Avorn; M H Beers; D E Everitt
Journal:  Arch Intern Med       Date:  1993-03-08

9.  Assessment of constipation management in long-term care patients.

Authors:  C Phillips; D Polakoff; S K Maue; R Mauch
Journal:  J Am Med Dir Assoc       Date:  2001 Jul-Aug       Impact factor: 4.669

10.  Constipation: assessment and management in an institutionalized elderly population.

Authors:  D Harari; J H Gurwitz; J Avorn; I Choodnovskiy; K L Minaker
Journal:  J Am Geriatr Soc       Date:  1994-09       Impact factor: 5.562

View more
  12 in total

1.  Tolerance and Long-Term Efficacy of Polyethylene Glycol 4000 (Forlax®) Compared to Lactulose in Elderly Patients with Chronic Constipation.

Authors:  P Chassagne; P Ducrotte; P Garnier; H Mathiex-Fortunet
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

2.  Review of efficacy and safety of laxatives use in geriatrics.

Authors:  Manhal Izzy; Anju Malieckal; Erin Little; Sury Anand
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-05-06

3.  Colonoscopy preparation: polyethylene glycol with Gatorade is as safe and efficacious as four liters of polyethylene glycol with balanced electrolytes.

Authors:  Thomas McKenna; Alice Macgill; Gail Porat; Frank K Friedenberg
Journal:  Dig Dis Sci       Date:  2012-06-19       Impact factor: 3.199

4.  Differences in taste between three polyethylene glycol preparations: a randomized double-blind study.

Authors:  Tze J Lam; Chris Jj Mulder; Richelle Jf Felt-Bersma
Journal:  Patient Prefer Adherence       Date:  2011-08-17       Impact factor: 2.711

5.  Macrogol (polyethylene glycol) 4000 without electrolytes in the symptomatic treatment of chronic constipation: a profile of its use.

Authors:  Katherine A Lyseng-Williamson
Journal:  Drugs Ther Perspect       Date:  2018-06-15

6.  The Relationship between Prebiotic Supplementation and Anthropometric and Biochemical Parameters in Patients with NAFLD-A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Ewa Stachowska; Piero Portincasa; Dominika Jamioł-Milc; Dominika Maciejewska-Markiewicz; Karolina Skonieczna-Żydecka
Journal:  Nutrients       Date:  2020-11-11       Impact factor: 5.717

7.  Efficacy and Safety of Over-the-Counter Therapies for Chronic Constipation: An Updated Systematic Review.

Authors:  Satish S C Rao; Darren M Brenner
Journal:  Am J Gastroenterol       Date:  2021-06-01       Impact factor: 12.045

8.  Laxative Use and Change in Estimated Glomerular Filtration Rate in Patients With Advanced Chronic Kidney Disease.

Authors:  Keiichi Sumida; Ankur A Dashputre; Praveen K Potukuchi; Fridtjof Thomas; Yoshitsugu Obi; Miklos Z Molnar; Justin D Gatwood; Elani Streja; Kamyar Kalantar-Zadeh; Csaba P Kovesdy
Journal:  J Ren Nutr       Date:  2020-09-18       Impact factor: 4.354

Review 9.  Comparison of the effectiveness of polyethylene glycol with and without electrolytes in constipation: a systematic review and network meta-analysis.

Authors:  Peter Katelaris; Vasi Naganathan; Ken Liu; George Krassas; John Gullotta
Journal:  BMC Gastroenterol       Date:  2016-03-31       Impact factor: 3.067

10.  Polyethylene Glycol 3350 With Electrolytes Versus Polyethylene Glycol 4000 for Constipation: A Randomized, Controlled Trial.

Authors:  Noor L H Bekkali; Daniël R Hoekman; Olivia Liem; Marloes E J Bongers; Michiel P van Wijk; Bas Zegers; Rolf A Pelleboer; Wim Verwijs; Bart G P Koot; Maksym Voropaiev; Marc A Benninga
Journal:  J Pediatr Gastroenterol Nutr       Date:  2018-01       Impact factor: 2.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.